Effectiveness of Chemotherapy and Radiotherapy in Sterilizing Cervical Nodal Disease in Squamous Cell Carcinoma of the Head and Neck
- 1 April 2005
- journal article
- clinical trial
- Published by Wiley in The Laryngoscope
- Vol. 115 (4) , 570-573
- https://doi.org/10.1097/01.mlg.0000161359.58567.0e
Abstract
Determine effects of chemoradiotherapy on nodal disease in head and neck squamous cell carcinoma (SCCA). Matched case-control study. A series of neck dissections (ND) performed for SCCA of the head and neck was retrospectively reviewed. Three groups were identified: 1) planned ND after chemoradiotherapy, 2) ND after radiotherapy alone, and 3) ND before adjuvant therapy (control group). Demographic data, tumor-node-metastasis stage, and pathology were reviewed. Total number of nodes recovered, number of positive nodes, and extracapsular spread (ECS) were recorded. To each patient in the chemoradiotherapy group, a randomly matched dissection in the control group was identified, matching for preoperative N stage and ND type (comprehensive, supraomohyoid, or selective). Comparisons were conducted for total nodes, presence of positive nodes, and ECS. Similar matched comparisons were conducted for ND after radiotherapy alone versus the control group. Ninety-seven NDs (N0 = 10 cases, N1 = 9, N2 = 69, and N3 = 9) were matched to control NDs without previous therapy. Total nodal yield was not statistically different between chemoradiotherapy and control groups (23.5 vs. 23.0 nodes, respectively, P = .77). Positive nodal yield was significantly lower for chemoradiotherapy versus control dissections (0.76 vs. 3.0, P < .001). The percent of chemoradiotherapy dissections recovered as positive nodes was 24.7% versus 68.0% of the control group (P < .001). ECS was identified in 13.4% of the chemoradiotherapy group versus 32.0% of the control group (P = .002). Radiotherapy alone produced less pronounced nodal reductions. Chemoradiotherapy substantially decreases nodal disease and ECS in SCCA. However, a significant percentage of necks contain positive nodes after therapy, meriting consideration for ND.Keywords
This publication has 14 references indexed in Scilit:
- Positron emission tomography with 18F‐fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancerHead & Neck, 2004
- Intensive Chemoradiotherapy as a Primary Treatment for Organ Preservation in Patients With Advanced Cancer of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 2004
- Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx CarcinomaJournal of Clinical Oncology, 2004
- Who merits a neck dissection after definitive chemoradiotherapy for N2–N3 squamous cell head and neck cancer?Head & Neck, 2003
- An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck CancerJournal of Clinical Oncology, 2003
- Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neckHead & Neck, 2002
- Combined Radiotherapy With Planned Neck Dissection for Small Head and Neck Cancers With Advanced Cervical MetastasesThe Laryngoscope, 2000
- The Role of Cervical Lymphadenectomy After Aggressive Concomitant ChemoradiotherapyJAMA Otolaryngology–Head & Neck Surgery, 2000
- Pain, Quality of Life, and Spinal Accessory Nerve Status After Neck DissectionThe Laryngoscope, 2000